Status:

RECRUITING

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

American Heart Association

Harvard Medical School (HMS and HSDM)

Conditions:

Cardiovascular Diseases

Eligibility:

All Genders

20+ years

Brief Summary

Hypothesis: The investigators hypothesize that genetic variants will alter gene expression in response to ischemia during cardiopulmonary bypass. To test this, the investigators will be taking small p...

Eligibility Criteria

Inclusion

  • Aged greater than 20 years
  • Undergoing aortic valve surgery with or without CABG surgery
  • Receive and apical vent as part of the surgery

Exclusion

  • Will not receive an apical left ventricular vent

Key Trial Info

Start Date :

March 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT00985049

Start Date

March 1 2009

End Date

December 1 2025

Last Update

August 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression) | DecenTrialz